Pyxis Diagnostics

AI-powered Cancer Diagnostics Platform for Predicting Immuno-oncology Drug Response

Health Tech & Life Sciences
Non Active, Nov 2025 ceased to operate
Seed Jerusalem, Israel Founded 2019
LinkedIn
Last updated 2026-06-18
Total raised
$1.2M
Last: 2019-09
Stage
Seed
Founded
2019
Headcount
4
HQ
Jerusalem, Israel
Sector
Health Tech & Life Sciences

About

Pyxis Diagnostics is developing an AI-powered cancer diagnostics platform for predicting immuno-oncology (IO) drug response. The company's platform can predict IO drug response for many cancer types. It can also suggest alternative treatment routes in cases when the predicted drug response is low, improving the quality of life of oncological patients. Biological data collected from fresh tumor samples (using cell sorting, next-generation genetic sequencing, and proteomics), enables deep characterization of the cancer cell, different immune cells, and stromal cells. This profound analysis allows for the delineation of the cellular suppressive network (CSN) formed within the tumor microenvironment. Machine-learning algorithms can then be used for classification of responders based on differential CSN patterns. Pyxis Diagnostics aims to improve outcomes for patients and increase success rates of immunotherapies both in clinics and during the drug-development process.

Funding history · 1 round · $1.2M total

Q&A

What is Pyxis Diagnostics' primary focus?
Pyxis Diagnostics is developing an AI-powered cancer diagnostics platform designed to predict immuno-oncology (IO) drug response and suggest alternative treatment routes for various cancer types.
When was Pyxis Diagnostics founded?
Pyxis Diagnostics was founded in April 2019.
What is the current status of Pyxis Diagnostics?
Pyxis Diagnostics is currently inactive, having ceased operations in November 2025.
How much funding has Pyxis Diagnostics raised in total?
Pyxis Diagnostics has raised a total of $1,200,000.
When was Pyxis Diagnostics' last funding round and who were the investors?
Pyxis Diagnostics' last funding round was in September 2019, with investors including Israel Innovation Authority.
What is the employee count for Pyxis Diagnostics?
Pyxis Diagnostics has 1-10 employees.
Where is Pyxis Diagnostics headquartered?
Pyxis Diagnostics is headquartered in Jerusalem, Israel.
What technologies does Pyxis Diagnostics utilize?
Pyxis Diagnostics utilizes Artificial Intelligence, Machine Learning, and Biologicals in its platform.

Team · 6

Founder · CMO
LinkedIn ↗
Founder · CSO
LinkedIn ↗
Founder · CTO
LinkedIn ↗
Founder · Head of Bioinformatics
LinkedIn ↗
Founder · Research & Development Scientist
LinkedIn ↗
Founder · Senior Scientist
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareDigital Medical Diagnostics
Technologies
Artificial IntelligenceMachine LearningBiologicals
Target customers
Healthcare & Life SciencesHealthcareProvidersLife SciencesPharmaceuticals
Business model
B2B

Highlights

Verified

Tags

clinical-trialsbiomarkersdiagnosticsimmunotherapypharma-companiesoncologyhospitalsmachine-learningbioinformaticscell-therapydigital-healthcareartificial-intelligencecancerbiotechnology
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

LinkedInlinkedin.com/company/69532570

Identifiers & details

Founded2019-4
Employees (exact)4
Status reasonNon Active, Nov 2025 ceased to operate